Agency Information Collection Activities; Announcement of OMB Approval; Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions

摘要

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.